Australasian Society for Dermatology Research Meeting, May 2006

    October 2007 in “ Journal of Investigative Dermatology ”
    SM Russell, MJ Ludford-Menting, Oliaro J Jane, Faruk Sacirbegovic, Ety Cheah, Natalie Pedersen, Serge Thomas, Anupama Pasam, Rosa M. Iazzolino, LE Dow, NE Waterhouse, Anthony B. Murphy, Sarah Ellis, MJ Smyth, MH Kershaw, PK Darcy, PO Humbert
    Image of study
    TLDR The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.
    The 3rd Annual Scientific Meeting of the Australasian Society for Dermatology Research in 2006 presented key findings on various dermatological topics. Notably, the heritability of female pattern hair loss (FPHL) was highlighted with a heritability score of 0.75 in a pilot study and 0.69-0.86 in a larger study. Other significant studies included the role of MC1R gene variants in skin cancer risk, the protective effects of Melanotan on UV damage, and the pathophysiology and treatment of pemphigus. Research also linked COL17A1 gene mutations to dental abnormalities in non-herlitz junctional epidermolysis bullosa and identified a subpopulation of mammary stem cells with potential implications for breast cancer. Additionally, studies on keratinocyte-derived VEGF, adipogenesis, and the transcription factor Grainyhead-like 3 in mice provided insights into skin health, tissue engineering, and wound repair. The meeting also discussed the role of E2F-1 in squamous cell carcinoma, glutathione peroxidase deficiency in UV-induced SCC, and the photoprotective properties of UVA radiation. Genetic studies on melanoma underscored the clinical heterogeneity of melanoma susceptibility.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Spironolactine Update: 2 months (34, Female)

      in Female  23 upvotes 7 years ago
      A female user's experience using Spironolactone to treat Female Pattern Hair Loss (FPHL) and Androgenic Alopecia, as well as discussing the effectiveness of the drug at different dosages.

      community For the ladies: Spironolactone for FPHL

      in Female  13 upvotes 8 years ago
      A 34 year old female with androgenic alopecia who has tried treatments such as Spironolactone, Desogen, Minoxidil and Finasteride in order to address her hair loss. It also details the experiences of other women taking Spironolactone for Female Pattern Hair Loss (FPHL).

    Similar Research

    5 / 1000+ results
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research 2015

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.